BEZ235 (NVP-BEZ235, Dactolisib)

Catalog No.S1009

BEZ235 (NVP-BEZ235, Dactolisib) is a dual ATP-competitive PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM in cell-free assays, respectively. Inhibits ATR with IC50 of 21 nM in 3T3TopBP1-ER cell.

Price Stock Quantity  
USD 110 In stock
USD 170 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

BEZ235 (NVP-BEZ235, Dactolisib) Chemical Structure

BEZ235 (NVP-BEZ235, Dactolisib) Chemical Structure
Molecular Weight: 469.55

Validation & Quality Control

Cited by 81 publications:

8 customer reviews :

Quality Control & MSDS

Related Compound Libraries

BEZ235 (NVP-BEZ235, Dactolisib) is available in the following compound libraries:

PI3K Inhibitors with Unique Features

Product Information

  • Compare PI3K
    Compare PI3K Products
  • Research Area
  • Inhibition Profile
  • Combination Therapy
    Combination Therapy

Product Description

Biological Activity

Description BEZ235 (NVP-BEZ235, Dactolisib) is a dual ATP-competitive PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM in cell-free assays, respectively. Inhibits ATR with IC50 of 21 nM in 3T3TopBP1-ER cell.
Targets p110α [1]
(Cell-free assay)
p110γ [1]
(Cell-free assay)
mTOR (p70S6K) [1]
(Cell-free assay)
p110δ [1]
(Cell-free assay)

 View  More

IC50 4 nM 5 nM 6 nM 7 nM
In vitro BEZ235 significantly reduces the phosphorylation levels of the mTOR activated kinase p70S6K. BEZ235 results in a reduction of S235/S236P-RPS6 levels with IC50 of 6.5 nM. The activity of BEZ235 against mTOR is determined using a biochemical mTOR K-LISA assay with IC50 of 20.7 nM. BEZ235 shows slightly lower activity against its β paralogue with IC50 of 75 nM. The PI3K/Akt/mTOR pathway is often constitutively activated in human tumor cells. BEZ235 blocks PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes. Both PTEN-null cell lines PC3M and U87MG show a dose-dependent reduction in cell proliferation when treated with increasing concentrations of BEZ235 with an average GI50 of 10-12 nM. [1] BEZ235 is an mTORC1/2 catalytic inhibitor. [2]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
Trypanosoma brucei bruceiNXvJPZZCSW62aX3pZ5Jw[mmjbDDBd5NigQ>?MkjUNVghcA>?NVjTNGxVTE2VTx?=M3LtfGFvfGm2conwZY5we2:vYXygZYN1cX[rdImge4l1cCCHQ{WwJI9nKDBwMECyOUDPxE1?NFrwb2czPDhyNUm0Oi=>
MCF7Ml\aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWLoT2kzOC5yMT2xNFAh|ryPMUm0PEBpMnHjSG1UVw>?NE\uUVdKSzVyPUCuO|Mh|ryPNFizN4wzOzh5MUmwOC=>
HCT116MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mk\yNE4xOS1zMECg{txOMVK0PEBpNFLMV5ZFVVORMWXJR|UxRTFwMU[g{txONI\HdYwzOzh5MUmwOC=>
U87MGM1OzOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVfI[oJLOC5yMT2xNFAh|ryPMnjxOFghcA>?NITXT4pFVVORM{\hWGlEPTB;MT6zNkDPxE1?M1fQPFI{QDdzOUC0
HBC4M1jJRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmGyNE4xOS1zMECg{txONITxNGM1QCCqMVnMc4chT0l3ME2tPE43OSCPM{LNOlIzOzN4MkS2
BSY1NXvRdYYyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYmwMlAyNTFyMDFOwG0>NIf3eZc1QCCqMYjMc4chT0l3ME2tPE41QCCPMXmyNlM{PjJ2Nh?=
HBC5MkHES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXjkT2FyOC5yMT2xNFAh|ryPMWW0PEBpMl;NUI9oKEeLNUC9MVcvQDdiTR?=M2m3TFIzOzN4MkS2
MCF7M{jZb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGXONYkxNjBzLUGwNEDPxE1?MU[0PEBpM{XsW2xw\yCJSUWwQU05NjF4IF2=M{HRNlIzOzN4MkS2
MDA-MB-231M{jLUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{jtTVAvODFvMUCwJO69VQ>?MX:0PEBpM{D4OWxw\yCJSUWwQU05NjB7IF2=NVPmSYg5OjJ|M{[yOFY>
U251NFLCOJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2SweFAvODFvMUCwJO69VQ>?MmnhOFghcA>?NYXUe4hJVG:pIFfJOVA:NTdwNk[gUS=>MnPUNlI{OzZ{NE[=
SF268MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1jDS|AvODFvMUCwJO69VQ>?NX;FR|F4PDhiaB?=Mkj1UI9oKEeLNUC9MVcvQTJiTR?=M2HQe|IzOzN4MkS2
SF295M4myS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYOwMlAyNTFyMDFOwG0>MoPiOFghcA>?NIfMS4tNd2diR1m1NF0uQC5|MTDNNWqxd2dXOjJ|M{[yOFY>
SF539NUS5c49bT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlfSNE4xOS1zMECg{txONVTqXYdRPDhiaB?=NXXlNpRRVG:pIFfJOVA:NThwNUmgUS=>NX\PfnpLOjJ|M{[yOFY>
SNB75MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFnIUG4xNjBzLUGwNEDPxE1?MX20PEBpMlPEUI9oKEeLNUC9MVgvPThiTR?=NWXJNGlYOjJ|M{[yOFY>
SNB78M3\HPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUKwMlAyNTFyMDFOwG0>NWjQW49PPDhiaB?=NGPGOWJNd2diR1m1NF0uQC54NTDNMU[yNlM{PjJ2Nh?=
HCC2998MlHtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUSwMlAyNTFyMDFOwG0>NXvldGx3PDhiaB?=MnjEUI9oKEeLNUC9MVgvODViTR?=NULVWoR2OjJ|M{[yOFY>
KM12M4XkWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUOwMlAyNTFyMDFOwG0>NVfESnltPDhiaB?=NF;Oe5BNd2diR1m1NF0uPy53NDDNMVGyNlM{PjJ2Nh?=
HT-29Ml:zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{ezdVAvODFvMUCwJO69VQ>?NYHaUWZsPDhiaB?=Mn;MUI9oKEeLNUC9MVcvPzViTR?=NVjnZpR7OjJ|M{[yOFY>
HCT15MmDTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVuwMlAyNTFyMDFOwG0>MUm0PEBpNEjLVWNNd2diR1m1NF0uQC5yMzDNMXuyNlM{PjJ2Nh?=
HCT116M1;wWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVuwMlAyNTFyMDFOwG0>MlLsOFghcA>?MUfMc4chT0l3ME2tO{43OSCPMmDSNlI{OzZ{NE[=
NCI-H23NFi1NGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4fwXlAvODFvMUCwJO69VQ>?MlTsOFghcA>?MoHwUI9oKEeLNUC9MVcvPjRiTR?=NUfEbFBuOjJ|M{[yOFY>
NCI-H226MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVywMlAyNTFyMDFOwG0>NHvDdIE1QCCqNVXIO3ZCVG:pIFfJOVA:NThwNESgUS=>NEjDbHAzOjN|NkK0Oi=>
NCI-H522NY\TPGtKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYm0XWFrOC5yMT2xNFAh|ryPNVLseFZlPDhiaB?=Ml\HUI9oKEeLNUC9MVgvPDViTR?=MYqyNlM{PjJ2Nh?=
NCI-H438MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2DKWVAvODFvMUCwJO69VQ>?NHnM[Ws1QCCqNH3G[nFNd2diR1m1NF0uQC5zMTDNMV:yNlM{PjJ2Nh?=
A549M2L4V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUPPTJZuOC5yMT2xNFAh|ryPMVe0PEBpM3;hUGxw\yCJSUWwQU05NjB5IF2=M1;EflIzOzN4MkS2
DMS273MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlXMNE4xOS1zMECg{txOMn2xOFghcA>?NHzJZXBNd2diR1m1NF0uPy56MDDNNWrWfJdwOjJ|M{[yOFY>
DMS114Mlq2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml\JNE4xOS1zMECg{txOMUe0PEBpMVHMc4chT0l3ME2tPE4{QSCPM2e0e|IzOzN4MkS2
LOXIMVIMXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmrKNE4xOS1zMECg{txONH[5cGU1QCCqNHvEPIZNd2diR1m1NF0uQC54NjDNNG\POYUzOjN|NkK0Oi=>
OVCAR3MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnX3NE4xOS1zMECg{txOMX60PEBpNWjBUoM4VG:pIFfJOVA:NThwMUegUS=>MVeyNlM{PjJ2Nh?=
OVCAR4NH2ydnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVnVcYxSOC5yMT2xNFAh|ryPNUjjSGFWPDhiaB?=MnjjUI9oKEeLNUC9MVgvPThiTR?=MVSyNlM{PjJ2Nh?=
OVCAR5Mom1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUOwMlAyNTFyMDFOwG0>M3W3c|Q5KGh?MV\Mc4chT0l3ME2tO{42PyCPNEK0VYczOjN|NkK0Oi=>
OVCAR8MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX[wMlAyNTFyMDFOwG0>MWW0PEBpMontUI9oKEeLNUC9MVcvQDRiTR?=NUW2d3lJOjJ|M{[yOFY>
SKOV3M2fxV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXSwMlAyNTFyMDFOwG0>M3;ic|Q5KGh?NF61UnVNd2diR1m1NF0uQC52MTDNNF60W44zOjN|NkK0Oi=>
RXF631LMUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWCwMlAyNTFyMDFOwG0>M4fRbVQ5KGh?M{L2VWxw\yCJSUWwQU05NjJzIF2=MofSNlI{OzZ{NE[=
ACHNMnvCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3G0[FAvODFvMUCwJO69VQ>?NH:2fXc1QCCqM{jSfmxw\yCJSUWwQU04Njl3IF2=MXiyNlM{PjJ2Nh?=
St-4NFXkVlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1rHZVAvODFvMUCwJO69VQ>?NILTc441QCCqNIOwR4tNd2diR1m1NF0uPy52NzDNM1K3TFIzOzN4MkS2
MKN1NHfCNJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGXOPVYxNjBzLUGwNEDPxE1?NWDHUnVYPDhiaB?=NXHJcWVPVG:pIFfJOVA:NThwNEGgUS=>MkPtNlI{OzZ{NE[=
MKN7NFXBe|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXuwMlAyNTFyMDFOwG0>MkT2OFghcA>?NHO5ZXBNd2diR1m1NF0uPy54ODDNMmjNNlI{OzZ{NE[=
MKN28MmPXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUiwMlAyNTFyMDFOwG0>MnnlOFghcA>?M2LqTmxw\yCJSUWwQU04NjB5IF2=M{S5SlIzOzN4MkS2
MKN45NYn5VldVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWTxfJlUOC5yMT2xNFAh|ryPNGP5V3U1QCCqNGLDXnpNd2diR1m1NF0uQC5|NDDNNYL1SoFzOjJ|M{[yOFY>
MKN74NHK5O2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3vRNFAvODFvMUCwJO69VQ>?MVK0PEBpM2jpfGxw\yCJSUWwQU04NjR{IF2=MUGyNlM{PjJ2Nh?=
DU145MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1TIfVAvODFvMUCwJO69VQ>?NVy1cItJPDhiaB?=MoTMUI9oKEeLNUC9MVgvOTZiTR?=MVKyNlM{PjJ2Nh?=
PC3MlO5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGPGdpgxNjBzLUGwNEDPxE1?NFftNlE1QCCqMnnHUI9oKEeLNUC9MVgvPjZiTR?=M{H2TFIzOzN4MkS2
Trypanosoma brucei bruceiMoXWSpVv[3Srb36gRZN{[Xl?M2HvVlIxOCCwTR?=MX6xNkBpNYXpV3o4TE2VTx?=MVzE[YNz\WG|ZTDpckBxcG:|cHjveIllgWxiaX7vd4l1d2xicHjvd5Bp[XSnIHzleoVtM4D3Z|I1QDB3OUS2
Trypanosoma brucei bruceiM4i0emZ2dmO2aX;uJGF{e2G7MWGxPEBpMkHKSG1UVw>?NGDKOpBKdmirYnn0bY9vKG:oIILlZ4VxfG:{LX3l[IlifGWmIHXu[I9kgXSxc3nzJIF{e2W|c3XkJIF{KGSnY4LlZZNmKGmwIITyZY5{\mW{cnnuJJVxfGGtZR?=MonsNlQ5ODV7NE[=
Trypanosoma brucei bruceiNYjKe3pMTnWwY4Tpc44hSXO|YYm=MWmyNFAhdk1?NHK3OFgyOiCqNYPkeVdTTE2VTx?=Mn3HSYZn\WO2IH;uJJNxcGmwZ3;tfYxmcW5ibHX2[Yw>MoSzNlQ5ODV7NE[=
Trypanosoma brucei bruceiM13KOGZ2dmO2aX;uJGF{e2G7NInQeo0zODBibl2=NY\sN4pPOTJiaB?=MV7EUXNQNGTsNHhG\m[nY4Sgc44heGixc4DoZZRq\HmuY3jvcIlv\SCuZY\lcC=>NEfvN3UzPDhyNUm0Oi=>
UM-UC-3MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUHSfGlbUUN3ME2zNVUheE1?MUDTRW5ITVJ?
SBC-1Mn\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXPje5BMUUN3ME23OFIheE1?NXfjdGYyW0GQR1XS
MKN1MojiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWHJR|UxRTJwODDuUS=>M{LpO3NCVkeHUh?=
NCI-H720MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF3STGZKSzVyPUOuOVchdk1?NX;qOo13W0GQR1XS
BFTC-909MkjBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{XHNGlEPTB;Mz63NUBvVQ>?NGXrbXVUSU6JRWK=
BPH-1NXXBRmg1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmrBTWM2OD12Lke2JI5OMV3TRW5ITVJ?
PC-3NIracVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkPvTWM2OD13LkC5JI5ONXOxNFFZW0GQR1XS
AN3-CANHXyOlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWXJR|UxRTVwNU[gcm0>M4nuUnNCVkeHUh?=
HNNXLtfVhwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX7JR|UxRTVwOU[gcm0>NHnmOY9USU6JRWK=
HCC2218M3i3Nmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXW4Z41zUUN3ME22MlYyKG6PNGO1OZRUSU6JRWK=
KP-4Mn3PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MofwTWM2OD15IH7NNFPP[3dUSU6JRWK=
LU-139M{LUO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmXHTWM2OD15Lke3JI5ONGLJToRUSU6JRWK=
ETK-1MnLpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4jVTmlEPTB;Nz64PEBvVQ>?NH\EUoxUSU6JRWK=
Ramos-2G6-4C10MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml6xTWM2OD16LkS5JI5OMoTOV2FPT0WU
MHH-PREB-1M{LRVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIm1ZlJKSzVyPUmuNVIhdk1?MmD3V2FPT0WU
DU-4475NUS2V3hDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1fa[2lEPTB;OT60OEBvVQ>?M4jOcXNCVkeHUh?=
NCI-H1666MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mm\3TWM2OD17LkexJI5OMWTTRW5ITVJ?
CAMA-1NHjVUVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1LKSWlEPTB;OT64JI5ONH;5VZNUSU6JRWK=
TYK-nuMn75S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4ribmlEPTB;OT65OEBvVQ>?M4HqbnNCVkeHUh?=
MFE-280M3fm[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1Tw[GlEPTB;OT65PUBvVQ>?MXHTRW5ITVJ?
A549MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXXJR|UxRTFyLkG0JI5OMWPTRW5ITVJ?
769-PNXH4VlJFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnHTTWM2OD1zMD60OEBvVQ>?M{GwXXNCVkeHUh?=
L-363NE\KRWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmD0TWM2OD1zMD62PUBvVQ>?NIfiV3ZUSU6JRWK=
ES8MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWT0bll5UUN3ME2xNE46KG6PMlzTV2FPT0WU
PA-1M{Ts[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkOyTWM2OD1zMT64NkBvVQ>?NWrseHp7W0GQR1XS
MewoM32wUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M36w[mlEPTB;MUGuPVkhdk1?MX\TRW5ITVJ?
HSC-3NF7QSGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml7CTWM2OD1zMj6yNUBvVQ>?M2jvNnNCVkeHUh?=
H4NUnEXJozT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlW2TWM2OD1zMj62O{BvVQ>?M1[1VXNCVkeHUh?=
BB65-RCCNFjNZopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH3ET3hKSzVyPUGyMlczKG6PM2XSfHNCVkeHUh?=
NCI-H1793MkDlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{j6R2lEPTB;MUKuPFIhdk1?M1\wPHNCVkeHUh?=
KARPAS-45M4DJ[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV7JR|UxRTF|LkWxJI5OM{O1U3NCVkeHUh?=
GCTNH\TWJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEP4bZRKSzVyPUGzMlY5KG6PNIXHSJhUSU6JRWK=
EoL-1M2THdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mk\UTWM2OD1zMz65N{BvVQ>?NIL4R3NUSU6JRWK=
LB2241-RCCNXH2V2dbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFLPVpZKSzVyPUG0MlAyKG6PNYHXb2JzW0GQR1XS
ES5M{Lh[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX3CWVMzUUN3ME2xOE44PCCwTR?=MoHNV2FPT0WU
LOXIMVIMmLOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkHLTWM2OD1zND65PUBvVQ>?M2TUR3NCVkeHUh?=
COR-L105NF;kVJVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX;JR|UxRTF3LkC0JI5OMXTTRW5ITVJ?
P12-ICHIKAWANWqyTlhZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVPJR|UxRTF3LkGgcm0>NGG0SJNUSU6JRWK=
CHL-1NYX3Ono6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVvJR|UxRTF3LkS1JI5OMUXTRW5ITVJ?
VMRC-RCZM2jqW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGTOTFNKSzVyPUG1MlY{KG6PNVnFVHRCW0GQR1XS
HHNH7EWG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlvaTWM2OD1zNT63JI5ONG[4TWFUSU6JRWK=
NUGC-3M2joVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml\vTWM2OD1zNj6zOEBvVQ>?M2\ob3NCVkeHUh?=
EGI-1M3vwbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWrJR|UxRTF4LkSzJI5OMnvSV2FPT0WU
OS-RC-2M2PqbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2qweGlEPTB;MU[uOFchdk1?NWfYZmE5W0GQR1XS
MOLT-16M17EWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkHvTWM2OD1zNz6xOUBvVQ>?M4DRS3NCVkeHUh?=
NCI-H209MojZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4W5VWlEPTB;MUeuNlkhdk1?M4i4eXNCVkeHUh?=
697Ml7nS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIrmfopKSzVyPUG3MlQ{KG6PMonQV2FPT0WU
D-56MGMoSxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3nPTmlEPTB;MUeuOlkhdk1?MW\TRW5ITVJ?
VA-ES-BJNX:3THZJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEnFXG5KSzVyPUG3Mlg{KG6PMnLoV2FPT0WU
EW-16NWLncJU{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnjVTWM2OD1zOD6wOEBvVQ>?MlS1V2FPT0WU
HGC-27M4XaZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3:ycmlEPTB;MUiuNFYhdk1?NH3YPWNUSU6JRWK=
ES7NH22UG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3HPTmlEPTB;MUiuNFkhdk1?NFWwSXRUSU6JRWK=
HuH-7MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVPJR|UxRTF6LkSgcm0>MWjTRW5ITVJ?
BCPAPNXjzOFNqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVm5VYl{UUN3ME2xPE43PSCwTR?=NHjQd5dUSU6JRWK=
SW1710NY\pPFdjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWC1[VJoUUN3ME2xPE44OiCwTR?=Mk\CV2FPT0WU
IST-MEL1MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NETheGZKSzVyPUG4Mlc4KG6PM2DUeHNCVkeHUh?=
SF295MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFS2XodKSzVyPUG4Mlk{KG6PMULTRW5ITVJ?
RPMI-7951M4XqXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoP6TWM2OD1zOT6yPEBvVQ>?Mmf5V2FPT0WU
SF126MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlzkTWM2OD1zOT60NUBvVQ>?M3r3eXNCVkeHUh?=
GAMGNEnFZ3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGS3[nhKSzVyPUG5MlQ5KG6PNEH3XnhUSU6JRWK=
KNS-81-FDNEnae2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2j3bGlEPTB;MUmuOVQhdk1?MmHtV2FPT0WU
RT-112NUHxUGFzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIXwepZKSzVyPUG5MlY3KG6PNYKyZ5JHW0GQR1XS
DELMYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWXIVFloUUN3ME2yNE41QSCwTR?=NETReHJUSU6JRWK=
CGTH-W-1NULPbVJ4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1fMbmlEPTB;MkCuOlMhdk1?NHTHdlFUSU6JRWK=
HOSMUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmqwTWM2OD1{MT6wOkBvVQ>?NYfvT2VuW0GQR1XS
ES4MljZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYOxTYtsUUN3ME2yNU4xQCCwTR?=NWDNN2ZjW0GQR1XS
RXF393MmTUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUDuUZVRUUN3ME2yNU41PSCwTR?=M3vuTnNCVkeHUh?=
NCI-H2030MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGrQellKSzVyPUKxMlUzKG6PMXPTRW5ITVJ?
YH-13M4\WOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVrUN4M{UUN3ME2yNU45QCCwTR?=MU\TRW5ITVJ?
HT-1080M3jJTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{fITGlEPTB;MkGuPVMhdk1?M1LTbXNCVkeHUh?=
NCI-SNU-1NYXxN3ZNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH65eGlKSzVyPUKxMlk2KG6PNGP3eYpUSU6JRWK=
G-402MlfhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWrqV5dsUUN3ME2yNk4yPiCwTR?=NUjVWVdsW0GQR1XS
786-0MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnrHTWM2OD1{Mj6yPUBvVQ>?NX[xdlM{W0GQR1XS
ME-180NFm5N4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFXQSJlKSzVyPUKyMlQ{KG6PM3Tz[3NCVkeHUh?=
NB69NVLRTWh1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2WxWWlEPTB;MkKuOVMhdk1?Mn7XV2FPT0WU
J-RT3-T3-5M172[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoLPTWM2OD1{Mj65OkBvVQ>?MYrTRW5ITVJ?
TGBC1TKBM3flRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1rTRmlEPTB;MkOuNFUhdk1?MlvrV2FPT0WU
SW780MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHXMSFJKSzVyPUKzMlE{KG6PMoDUV2FPT0WU
MG-63MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mlv6TWM2OD1{Mz60OUBvVQ>?NETJVXBUSU6JRWK=
BV-173MnnCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFPYOIJKSzVyPUKzMlg4KG6PNXHFeZlOW0GQR1XS
CAL-51M{nCSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVTJR|UxRTJ|Lki5JI5OMl\YV2FPT0WU
A375MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX;JR|UxRTJ|LkmzJI5OMXjTRW5ITVJ?
MEL-HOMlXYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX;JR|UxRTJ2LkC0JI5OM{X4V3NCVkeHUh?=
EFO-27NUHzU2tXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYfmWoJsUUN3ME2yOE4{OyCwTR?=MWHTRW5ITVJ?
Hs-578-TM2L1bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1HQSmlEPTB;MkSuOVghdk1?M4XkdHNCVkeHUh?=
NBsusSRNVLCcJRoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGm2XWlKSzVyPUK0MlYhdk1?MV3TRW5ITVJ?
CTB-1Mn7jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4THOmlEPTB;MkSuOlchdk1?NUj2UZo5W0GQR1XS
FTC-133NWHW[Ic6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYXI[mJ5UUN3ME2yOU4yKG6PMVnTRW5ITVJ?
MOLT-4Mly5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFvVVmVKSzVyPUK1MlEzKG6PNFL1cnRUSU6JRWK=
HO-1-N-1NF7aWppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmjITWM2OD1{NT6xOUBvVQ>?NFnh[3pUSU6JRWK=
ES3MlyxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2DtRWlEPTB;MkWuNlIhdk1?MkfwV2FPT0WU
TI-73MkW3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mk\xTWM2OD1{NT6yPEBvVQ>?NGr0VpdUSU6JRWK=
MPP-89M2PnVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGn1bXFKSzVyPUK1MlMzKG6PMXfTRW5ITVJ?
KYSE-150MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVfJR|UxRTJ3Lki5JI5OM4L1[XNCVkeHUh?=
LXF-289NUfRcGdoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVjVWmJ4UUN3ME2yOk4xPCCwTR?=M1LZWXNCVkeHUh?=
SK-LU-1MnfWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3izZWlEPTB;Mk[uNVchdk1?Mk\XV2FPT0WU
HOP-92M4XhSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUPpUVlyUUN3ME2yOk41QCCwTR?=NIGxTW1USU6JRWK=
HuO9MkfTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUjJR|UxRTJ4Lke2JI5ONIXUSFRUSU6JRWK=
SW962NFzxXXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlP1TWM2OD1{Nj63OkBvVQ>?MV;TRW5ITVJ?
RS4-11MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2i1WmlEPTB;Mk[uPVEhdk1?NF7xb5JUSU6JRWK=
NCI-H292M2K2fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoDLTWM2OD1{NzDuUS=>M2DmWXNCVkeHUh?=
DBMk[1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnHXTWM2OD1{Nz6zOkBvVQ>?M2fQfnNCVkeHUh?=
SW1088MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH\WRpdKSzVyPUK4MlI6KG6PNX7VPVQ5W0GQR1XS
A204M4fqW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmTYTWM2OD1{OD60O{BvVQ>?NEPiRVFUSU6JRWK=
A3-KAWNFTS[4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1rzXWlEPTB;MkiuOlQhdk1?NW\hT4pOW0GQR1XS
MV-4-11Mk\SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFTCb45KSzVyPUK4Mlchdk1?NEfzeoJUSU6JRWK=
ES1M1ywbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlPKTWM2OD1{OD64OEBvVQ>?NVPLPXJtW0GQR1XS
ONS-76NVG4[Y1NT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn\3TWM2OD1{OT6wOUBvVQ>?MnjUV2FPT0WU
D-263MGMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUPmc3JZUUN3ME2yPU4{PSCwTR?=NHnpeo5USU6JRWK=
U-2-OSM2TBdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWTJR|UxRTJ7LkWgcm0>M4HoTXNCVkeHUh?=
T98GNV\kfHZ[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWDocndnUUN3ME2yPU45QCCwTR?=M3ToeHNCVkeHUh?=
GI-ME-NNFG4dnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn\aTWM2OD1{OT65NUBvVQ>?MYDTRW5ITVJ?
BHT-101Mnz4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHHtVmlKSzVyPUOwMlA2KG6PNUfMWHBvW0GQR1XS
NOS-1NEPBcHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWnJR|UxRTNyLkGyJI5ONIO1enBUSU6JRWK=
AsPC-1NHX4[pJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIWzOphKSzVyPUOwMlIhdk1?NWK1bGxyW0GQR1XS
QIMR-WILNXTQeGliT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVLJR|UxRTNyLk[gcm0>MoD4V2FPT0WU
JVM-3NU\FV|M6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkHFTWM2OD1|MD64N{BvVQ>?MYjTRW5ITVJ?
KU-19-19NYDHcodDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{TEe2lEPTB;M{GuNVMhdk1?M3XrbnNCVkeHUh?=
OVCAR-8MmHKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmfXTWM2OD1|MT6yOkBvVQ>?M4Tm[XNCVkeHUh?=
BENNFT2PYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHS3bmNKSzVyPUOxMlY{KG6PMYLTRW5ITVJ?
BE-13MmPrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlPNTWM2OD1|MT64NkBvVQ>?NFfPNXpUSU6JRWK=
EW-18MoDBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1W0c2lEPTB;M{GuPFYhdk1?M3\IfnNCVkeHUh?=
ECC10NF;UNIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoSwTWM2OD1|MT65OUBvVQ>?MVHTRW5ITVJ?
CTV-1NEnEOFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYXuSXgzUUN3ME2zNk45OiCwTR?=M4XjO3NCVkeHUh?=
COLO-800NH\j[YpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXfDOYlSUUN3ME2zNk46OiCwTR?=M3zyT3NCVkeHUh?=
A2058NITmfoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWLJR|UxRTN|LkK1JI5OM3z1b3NCVkeHUh?=
VM-CUB-1NXH4PYxZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlTSTWM2OD1|Mz60N{BvVQ>?MWjTRW5ITVJ?
Ca9-22NFjRXlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUTHe5ZiUUN3ME2zN{42PSCwTR?=NYPv[GJiW0GQR1XS
COLO-684NV7rOZBHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXvJR|UxRTN|LkW4JI5ONEfpRYlUSU6JRWK=
RPMI-8226NXrCZZhPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M33XeWlEPTB;M{OuPFIhdk1?MXnTRW5ITVJ?
SK-NEP-1MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn;NTWM2OD1|ND6xOUBvVQ>?NWLBV4pNW0GQR1XS
BeckerNHzoSo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTN2LkKxJI5ONVvOSYZHW0GQR1XS
NCI-H28M1PDW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1z1b2lEPTB;M{SuOFQhdk1?NUmwUYxIW0GQR1XS
CAL-120NIPp[XJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH7kb41KSzVyPUO0MlczKG6PM{XqUXNCVkeHUh?=
MDA-MB-157M4\jUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1vvfGlEPTB;M{WuOFEhdk1?M2TzfXNCVkeHUh?=
OVCAR-5Mm\yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUDIb4hpUUN3ME2zOU41PyCwTR?=M2XsWnNCVkeHUh?=
LAMA-84M2exRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkKxTWM2OD1|NT64O{BvVQ>?MWLTRW5ITVJ?
CAKI-1NVHXNY4xT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF;6N4VKSzVyPUO2MlQ{KG6PNIDVZ3pUSU6JRWK=
DaoyMWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mm[5TWM2OD1|Nj63JI5OM2LTdnNCVkeHUh?=
CAL-62NEDtdZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGrXTGVKSzVyPUO2Mlg3KG6PMl\sV2FPT0WU
8-MG-BANHjsTXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXKwXW12UUN3ME2zO{4zPSCwTR?=NXnHe41kW0GQR1XS
8505CNWTFR49XT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnnQTWM2OD1|Nz61NUBvVQ>?MX;TRW5ITVJ?
LNCaP-Clone-FGCNXnGToIyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M17qdmlEPTB;M{euOVkhdk1?MkTBV2FPT0WU
CAL-39MoDKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1;6[2lEPTB;M{euPUBvVQ>?NFHjWG9USU6JRWK=
MN-60MoK5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYXXOXR7UUN3ME2zO{46PiCwTR?=Mm[yV2FPT0WU
RKONVXROpp6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4D3N2lEPTB;M{iuN|Mhdk1?NX;OWYNxW0GQR1XS
U251Mo\RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXfJR|UxRTN6LkSzJI5OMXzTRW5ITVJ?
SJSA-1NV;SdnYxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVXJR|UxRTN6LkW0JI5OMmrhV2FPT0WU
CAL-12TM1TkOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlH2TWM2OD1|OD62JI5OMUDTRW5ITVJ?
HCC1419M3zTR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYnJR|UxRTN6LkexJI5OMXzTRW5ITVJ?
CO-314NH2zV5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmO4TWM2OD1|OD63OEBvVQ>?M32wenNCVkeHUh?=
LB1047-RCCNFvqbGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlfhTWM2OD1|OD64NUBvVQ>?MoLwV2FPT0WU
A101DMlTGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYXJR|UxRTN6Lkm3JI5OMlSyV2FPT0WU
MDA-MB-175-VIIMVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWrJR|UxRTN7LkWxJI5ONWTydJB[W0GQR1XS
MZ2-MELMV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXHJR|UxRTN7Lk[2JI5ONYHvR|JQW0GQR1XS
NB5MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mnv2TWM2OD12MD62OEBvVQ>?MlPsV2FPT0WU
G-401M{\qOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXTJR|UxRTRyLkiyJI5OMYPTRW5ITVJ?
HTMlX4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M16zdGlEPTB;NEGuNFIhdk1?NUnadVFkW0GQR1XS
8305CM1:xdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHfFVWtKSzVyPUSxMlg4KG6PMm\NV2FPT0WU
BHYMUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXzJR|UxRTR{LkeyJI5OMof1V2FPT0WU
NTERA-S-cl-D1MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF;CeVdKSzVyPUSzJI5OMVjTRW5ITVJ?
T-24NV7Ub2xMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGP1Z3lKSzVyPUSzMlg{KG6PMUfTRW5ITVJ?
EPLC-272HMX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MofyTWM2OD12ND6zPUBvVQ>?NIWzZlFUSU6JRWK=
PSN1NH\FfoxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnTFTWM2OD12ND60JI5OMXXTRW5ITVJ?
NCI-H2452MmToS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2O3W2lEPTB;NESuOVghdk1?NXnSWWpkW0GQR1XS
KS-1M4KyZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHjXendKSzVyPUS0MlY3KG6PM3vaUXNCVkeHUh?=
HD-MY-ZNWnaR3VFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1O0fGlEPTB;NESuPVIhdk1?M2PNb3NCVkeHUh?=
KNS-62NH74bYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlPvTWM2OD12NT6zPEBvVQ>?M1jTZ3NCVkeHUh?=
NOMO-1M1vHfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NU\zWlJWUUN3ME20OU45PyCwTR?=M4TIRXNCVkeHUh?=
SK-HEP-1NF;CdpBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M17pd2lEPTB;NE[uNFQhdk1?M{fhZXNCVkeHUh?=
IGR-1MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmjSTWM2OD12Nj6xN{BvVQ>?MoPaV2FPT0WU
KYSE-180NWr2OWRPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NW\NOIJGUUN3ME20Ok4yPyCwTR?=M2jKUHNCVkeHUh?=
EW-22M4XQb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHLmVlRKSzVyPUS2MlIhdk1?M3nBcXNCVkeHUh?=
NCI-H1355M{O5WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXLJR|UxRTR4LkO0JI5ONIe2Uo1USU6JRWK=
DOHH-2MlH2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M33YZ2lEPTB;NE[uN|chdk1?NEXnUodUSU6JRWK=
A4-FukNIK0OYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUPaXnlUUUN3ME20Ok42OiCwTR?=NVP4Z2J5W0GQR1XS
PC-14M2fTWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTR4LkW3JI5OMl\RV2FPT0WU
TE-5MmrzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYXJR|UxRTR4Lki0JI5OM4X4TnNCVkeHUh?=
LB996-RCCM2DsUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWOwXmpZUUN3ME20O{4yQSCwTR?=MXXTRW5ITVJ?
NCI-H1623Mn7JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlftTWM2OD12Nz63OkBvVQ>?MoDLV2FPT0WU
NCI-H1155NI\qUmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoDoTWM2OD12OD6zNkBvVQ>?M1[0VHNCVkeHUh?=
LoVoMkjpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkO4TWM2OD12OD60JI5OM4\ofXNCVkeHUh?=
MCF7MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmP2TWM2OD12OD61PEBvVQ>?NIG0bmpUSU6JRWK=
AGSM3;nW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmHITWM2OD12OD63O{BvVQ>?MVTTRW5ITVJ?
PFSK-1NW\NWYVjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEnCS|dKSzVyPUS5MlA3KG6PM2W5d3NCVkeHUh?=
22RV1NHzDZWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmPPTWM2OD12OT6wPUBvVQ>?MY\TRW5ITVJ?
COR-L23MkLWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoDETWM2OD12OT6xOkBvVQ>?M2jKWXNCVkeHUh?=
D-283MEDM3;qTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVfJR|UxRTR7Lk[xJI5OMWjTRW5ITVJ?
SW982MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGHkRoFKSzVyPUS5MlkyKG6PM{HQOHNCVkeHUh?=
SW620MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUG4UmNpUUN3ME21NE4{PiCwTR?=MVrTRW5ITVJ?
KYSE-140M{Ps[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MULJR|UxRTVyLkW1JI5ONF[zWWFUSU6JRWK=
GCIYM3zoRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV3qWXc{UUN3ME21NE43PyCwTR?=NVHMZ3p2W0GQR1XS
MHH-ESS-1M3q3VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHG2W3hKSzVyPUWxMlk2KG6PM{DpdHNCVkeHUh?=
D-423MGNH;sNFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{DGbmlEPTB;NUKuNFghdk1?MUDTRW5ITVJ?
SF539Mn72S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MU\JR|UxRTV{LkO1JI5OM4Ty[XNCVkeHUh?=
RPMI-2650NWPv[FlUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXTJR|UxRTV{Lk[5JI5OM1HBS3NCVkeHUh?=
GR-STM4LB[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkHUTWM2OD13Mj64O{BvVQ>?MWjTRW5ITVJ?
YKG-1MlK3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NILGT5VKSzVyPUWzJI5ONGDNXWNUSU6JRWK=
SK-MES-1M3\VTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mkf1TWM2OD13Mz6yOkBvVQ>?MU\TRW5ITVJ?
HLEMV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkDxTWM2OD13Mz60O{BvVQ>?NHr1bnpUSU6JRWK=
RVH-421NX;0[Xg1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1O1[2lEPTB;NUOuOlchdk1?M{PSd3NCVkeHUh?=
C32NG\GPXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVzJR|UxRTV|LkizJI5ONEDvO3lUSU6JRWK=
GB-1MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2jQSmlEPTB;NUSuNkBvVQ>?NETuZZlUSU6JRWK=
SNB75NGnxUHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFzN[VdKSzVyPUW0MlI3KG6PMX3TRW5ITVJ?
EM-2M4XCcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXzJR|UxRTV2LkSgcm0>MUjTRW5ITVJ?
RH-1MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYjJR|UxRTV2Lkegcm0>MXHTRW5ITVJ?
NKM-1NGnqcGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1rMWGlEPTB;NUSuPFEhdk1?MlywV2FPT0WU
NCI-H2405NVfDR|A{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX;JR|UxRTV2Lki4JI5OM2nUUXNCVkeHUh?=
KYSE-450MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWnJR|UxRTV3LkG2JI5ONIKxfFlUSU6JRWK=
A704MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml;2TWM2OD13NT61PUBvVQ>?NEGwPWxUSU6JRWK=
HAL-01NIHVWVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnLjTWM2OD13NT64N{BvVQ>?MXvTRW5ITVJ?
TE-11MmTjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYPIe4x{UUN3ME21OU46QSCwTR?=NEfHZYxUSU6JRWK=
DOKNYX2WlJGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIDBfZhKSzVyPUW2MlAzKG6PM37GUnNCVkeHUh?=
KY821Mk\0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn23TWM2OD13Nj6yJI5ONXr5Vo0zW0GQR1XS
KGNNVzLV3Z{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVfJR|UxRTV4LkOyJI5OMYHTRW5ITVJ?
MC116M3LLbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NULxcXJmUUN3ME21O{45KG6PM1vhRXNCVkeHUh?=
PANC-08-13MlzPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NITDSZNKSzVyPUW4MlAyKG6PMkjYV2FPT0WU
KE-37MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MljlTWM2OD13OD63O{BvVQ>?NV7HfZRpW0GQR1XS
KYSE-410NHrYNGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGHGT4NKSzVyPUW5MlQ4KG6PNEO5U|ZUSU6JRWK=
RO82-W-1NX3GS45bT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWTJR|UxRTV7Lkmgcm0>M37UTnNCVkeHUh?=
M14NGnpT2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mli4TWM2OD14MD6wOEBvVQ>?MWTTRW5ITVJ?
GI-1M3P0NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoXyTWM2OD14MD6zJI5OM1n3dXNCVkeHUh?=
ML-2NInIOo5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXLJR|UxRTZyLk[yJI5OMVXTRW5ITVJ?
BFTC-905NYizUo5ST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV7JR|UxRTZyLk[1JI5OM1PYRXNCVkeHUh?=
DMS-273NHPV[3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEPaeFhKSzVyPU[wMlg4KG6PNHLwTW9USU6JRWK=
MDA-MB-361MoLMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmLMTWM2OD14MTDuUS=>M1H1cXNCVkeHUh?=
MSTO-211HNWPlRVA4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml[3TWM2OD14Mz61NUBvVQ>?NVHUUGxxW0GQR1XS
MEG-01M{PRdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWTDTnZHUUN3ME22N{42OiCwTR?=MnrNV2FPT0WU
M059JMmHyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYDrZ4J7UUN3ME22N{42QCCwTR?=MYXTRW5ITVJ?
LN-405MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYTBZnJGUUN3ME22N{45PSCwTR?=Mkn1V2FPT0WU
NCI-H1581NUHKSmtST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{HQXmlEPTB;NkSuNFMhdk1?NGSycmhUSU6JRWK=
TCCSUPNX3LT4x1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHjJfm1KSzVyPU[0MlU{KG6PNEHuOpRUSU6JRWK=
SW872M3XVOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml7tTWM2OD14ND61O{BvVQ>?MmGzV2FPT0WU
KYSE-510NIj3N5NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVPtUFVzUUN3ME22OU44PSCwTR?=MYLTRW5ITVJ?
NCI-H1792M4HOV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4fJN2lEPTB;Nk[uNVUhdk1?NX7oeYVYW0GQR1XS
SW13M{TQeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3joTmlEPTB;Nk[uOUBvVQ>?MmTCV2FPT0WU
TE-8NFXPUmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2HyW2lEPTB;Nk[uOVIhdk1?NXL0PIVUW0GQR1XS
SCHNUTQcIZRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEG4[opKSzVyPU[3MlEhdk1?NF30dVZUSU6JRWK=
NEC8MknFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWCxe3lbUUN3ME22O{4zPCCwTR?=NIW3PZZUSU6JRWK=
HuO-3N1M3HpWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUfJR|UxRTZ5LkOxJI5ONHrL[mZUSU6JRWK=
EFM-19MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4rVNWlEPTB;NkeuOUBvVQ>?MXnTRW5ITVJ?
HEC-1MofnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHS4UnBKSzVyPU[3MlUzKG6PNHy5[lJUSU6JRWK=
T47DMW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1TvN2lEPTB;NkeuPFchdk1?M4HrbHNCVkeHUh?=
SNU-423MkfzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHHXR3RKSzVyPU[3Mlk5KG6PNVLt[mx2W0GQR1XS
WM-115NHfzUnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mmr2TWM2OD14OD6xOEBvVQ>?NYPMdGNFW0GQR1XS
CaR-1MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mlf2TWM2OD14OD6yOUBvVQ>?M37OVnNCVkeHUh?=
KU812MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHv6S4NKSzVyPU[4MlY6KG6PM2e0XHNCVkeHUh?=
AM-38M3;LRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVjjVYNpUUN3ME22PU4{OSCwTR?=MYPTRW5ITVJ?
KOSC-2MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYTJR|UxRTZ7Lkm3JI5OM1vYV3NCVkeHUh?=
MC-IXCMoDuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHG2S2tKSzVyPUewMlA5KG6PNYK4ZVQ1W0GQR1XS
SCC-4MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYnC[5BpUUN3ME23NU4{QCCwTR?=MVrTRW5ITVJ?
Calu-3MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1TFOGlEPTB;N{GuPVghdk1?NXW0NVFZW0GQR1XS
RPMI-8866MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4fLZ2lEPTB;N{KuPFIhdk1?MlH4V2FPT0WU
OVCAR-4NFvIPHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MorOTWM2OD15Mz6zOkBvVQ>?NIfsTYhUSU6JRWK=
OAW-42NIXjTIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUfkVY1YUUN3ME23N{4{QSCwTR?=NUO1SHdQW0GQR1XS
ATN-1NU\Qd5ZjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUPJR|UxRTd|Lki3JI5OMYPTRW5ITVJ?
CHP-212M2PrRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGn6dlFKSzVyPUe0Mlk2KG6PM4ftcnNCVkeHUh?=
C2BBe1M3zuUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmfSTWM2OD15NT6wN{BvVQ>?NWi3bJN4W0GQR1XS
A498NWXLeVl6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2\aXGlEPTB;N{WuNVUhdk1?NH\lNoFUSU6JRWK=
SH-4M4rDRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnTQTWM2OD15NT6yNUBvVQ>?MWXTRW5ITVJ?
SNU-449NVK1do9VT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUDJR|UxRTd3Lke5JI5ONXLQOod[W0GQR1XS
RDMXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEe3TndKSzVyPUe1Mlg3KG6PNXjUO3JiW0GQR1XS
PANC-03-27NE\lU49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX3JR|UxRTd4LkK1JI5ONEiwSHZUSU6JRWK=
S-117MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWLGSVJSUUN3ME23Ok4zPyCwTR?=NH7mU5lUSU6JRWK=
SK-MEL-2NXvTNJZ5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4e5WGlEPTB;N{[uO|Uhdk1?NHXYbnNUSU6JRWK=
LK-2NGPYV|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mke2TWM2OD15Nz6wOUBvVQ>?NGmy[5VUSU6JRWK=
CP50-MEL-BM4jiVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVK1TWt1UUN3ME23O{41KG6PNUnzZos6W0GQR1XS
647-VNF\vblhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4LWPGlEPTB;N{iuNFchdk1?M1zwXXNCVkeHUh?=
LU-134-AM1;S[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2radWlEPTB;N{muNFMhdk1?NHTjbIJUSU6JRWK=
5637NIrOV4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVPxUHZwUUN3ME23PU4zOyCwTR?=NETHfFNUSU6JRWK=
NCI-H1437NWPhd41UT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHHPcWlKSzVyPUiwMlUhdk1?M3HPOXNCVkeHUh?=
NCI-H460NFHzXYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M37OSGlEPTB;OEGuNlMhdk1?NES0SYZUSU6JRWK=
BxPC-3M123T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlnkTWM2OD16MT60OkBvVQ>?MV\TRW5ITVJ?
CANM4PNUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn3PTWM2OD16MT64OEBvVQ>?M{Ts[3NCVkeHUh?=
KINGS-1NHO2XldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXztTY9{UUN3ME24Nk4{OiCwTR?=MnzGV2FPT0WU
OCUB-MMni2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXfBUY1pUUN3ME24Nk41OSCwTR?=NIfW[21USU6JRWK=
KALS-1MoHzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml72TWM2OD16Mj61OEBvVQ>?Mn23V2FPT0WU
OCI-AML2MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUfJR|UxRTh{Lk[xJI5OM1nqTXNCVkeHUh?=
A253M{XDXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkPITWM2OD16Mj62OUBvVQ>?NHTISo5USU6JRWK=
LCLC-97TM1MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF;zPYtKSzVyPUiyMlg3KG6PM1ftTXNCVkeHUh?=
NCI-H520NUXqell[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{\PfWlEPTB;OEOuNFYhdk1?M4fwNHNCVkeHUh?=
P30-OHKMXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYPMZlNYUUN3ME24N{42KG6PNI\kTnNUSU6JRWK=
SBC-5NI\3TYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWjJR|UxRTh|LkWyJI5OMkXpV2FPT0WU
HCE-TNX25WoFTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4jpUGlEPTB;OEOuO|Qhdk1?MXHTRW5ITVJ?
JEG-3MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlvDTWM2OD16ND6xJI5OMXzTRW5ITVJ?
KG-1NI\KW49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3LDNWlEPTB;OESuNlQhdk1?MULTRW5ITVJ?
MIA-PaCa-2NXX3emkyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHGyUHlKSzVyPUi0MlU1KG6PMl3aV2FPT0WU
CAL-33MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF36PHNKSzVyPUi1MlA5KG6PNF3s[3lUSU6JRWK=
639-VMYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXTJR|UxRTh3LkSyJI5OMVzTRW5ITVJ?
NCI-H1048Mm\GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVfJR|UxRTh4LkOxJI5OMVLTRW5ITVJ?
NCI-H1573NG\1NpRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlvHTWM2OD16Nz60PEBvVQ>?M1rtZnNCVkeHUh?=
NCI-H2228MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX7Ee5o4UUN3ME24PE4zPiCwTR?=MlTQV2FPT0WU
NB14MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4rkO2lEPTB;OEiuN{BvVQ>?M4\2fHNCVkeHUh?=
SCC-25MkHnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEL2Zo1KSzVyPUi5MlgzKG6PNXzQeoxPW0GQR1XS
A431NYHaeW17T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mlr3TWM2OD16OT65O{BvVQ>?NU\KSol1W0GQR1XS
SN12CNWHRS4s6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF7YeItKSzVyPUmwMlYzKG6PNXj3T4F2W0GQR1XS
HuCCT1MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF\3S|NKSzVyPUmwMlc3KG6PM3XWT3NCVkeHUh?=
LS-123M2PFXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF;5XpBKSzVyPUmyMlE5KG6PNXPpN3FnW0GQR1XS
CAL-85-1NIXYc45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmXzTWM2OD17Mj60PEBvVQ>?M{LPcnNCVkeHUh?=
ES6NWLXN5BbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYXpUG9yUUN3ME25Nk45OyCwTR?=NXPXXJZNW0GQR1XS
NCI-H650MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGjzOHNKSzVyPUm0MlA6KG6PM{Xt[XNCVkeHUh?=
NCI-H446MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4HjeWlEPTB;OUWuNVIhdk1?M362XnNCVkeHUh?=
EW-13Mor5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUGxUnRVUUN3ME25OU44PSCwTR?=MUfTRW5ITVJ?
HSC-2M13yeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVLJR|UxRTl3Lki5JI5OMo\IV2FPT0WU
U031NFHFboxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3HifWlEPTB;OU[uO|Mhdk1?NGPhOoxUSU6JRWK=
EW-11NUfxWVNLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHOyUW9KSzVyPUm2Mlg5KG6PNF;NXHFUSU6JRWK=
GAKNUHrc212T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1rxdGlEPTB;OUiuPVMhdk1?M4WxT3NCVkeHUh?=
SK-OV-3NVv0TmF7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIrDNlhKSzVyPUGwNE4xPyCwTR?=M4nWbHNCVkeHUh?=
OMC-1NWewbmZkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVLQSYxMUUN3ME2xNFAvOThibl2=NXPqbol4W0GQR1XS
TK10NYnmW|JoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M33kW2lEPTB;MUCwMlIyKG6PNXfMbJRVW0GQR1XS
EKVXMknZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF7yW2pKSzVyPUGwNE43KG6PMVvTRW5ITVJ?
Detroit562MkjTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmjsTWM2OD1zMEKuNVchdk1?MVjTRW5ITVJ?
SF268MoTWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3HsXWlEPTB;MUCyMlM1KG6PNEDZZm9USU6JRWK=
SNU-387NHnCWYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{nlZWlEPTB;MUC0MlE4KG6PM{DY[3NCVkeHUh?=
MDA-MB-231M4LBeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV7JR|UxRTFyNT6wOkBvVQ>?M{DBOXNCVkeHUh?=
NCI-H1563MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX3wVlRFUUN3ME2xNFUvOThibl2=M4XwTnNCVkeHUh?=
D-502MGM2DnRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmrCTWM2OD1zMEWuO{BvVQ>?M3nSXnNCVkeHUh?=
A2780NHK1cFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mlz5TWM2OD1zME[uOFchdk1?NEmxRpZUSU6JRWK=
IA-LMNI\lblFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4XQdGlEPTB;MUC3MlUyKG6PMoG4V2FPT0WU
D-392MGNFy1TmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M17IfmlEPTB;MUC3MlU1KG6PNYflfmpnW0GQR1XS
MS-1M{HLWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGnQPHdKSzVyPUGwO{44OSCwTR?=M3G2cXNCVkeHUh?=
SW1990MmLUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkLRTWM2OD1zMEiuOVQhdk1?M1zXXHNCVkeHUh?=
HELNGLacVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXHKSog{UUN3ME2xNFkvOjlibl2=MoXaV2FPT0WU
SW1573MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEe1UZZKSzVyPUGwPU4{OSCwTR?=MWrTRW5ITVJ?
SW1783MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkG0TWM2OD1zMUCuNlIhdk1?M4PSOHNCVkeHUh?=
COLO-680NNETBRYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{D6UmlEPTB;MUGwMlc3KG6PM1:wSHNCVkeHUh?=
NCI-N87NYrNUZpUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUfJR|UxRTFzMT6wOEBvVQ>?M1S3eHNCVkeHUh?=
SK-MEL-28M1zjUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NU\wPZZOUUN3ME2xNVEvPTVibl2=M1[1fXNCVkeHUh?=
BT-20NY\tW4w{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUHJR|UxRTFzMj6wNUBvVQ>?MlTNV2FPT0WU
NCI-H1648M4fVXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXLJR|UxRTFzMzDuUS=>NFvQSpVUSU6JRWK=
no-11M3\pPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWfJR|UxRTFzMz6yPEBvVQ>?NVvVV5c2W0GQR1XS
MOLT-13MoSxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2DUR2lEPTB;MUGzMlQ1KG6PM1SyVnNCVkeHUh?=
NCI-H2170M2nDT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXXJR|UxRTFzND61NUBvVQ>?NGXyTVRUSU6JRWK=
HTC-C3NXX0[VN{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHPFVZFKSzVyPUGxOk45PSCwTR?=M3jWcXNCVkeHUh?=
LU-99AM3Xnfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWLoUYpDUUN3ME2xNVcvOjFibl2=NVTXRYp3W0GQR1XS
HCC2998NEP4cWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIPUTYRKSzVyPUGxO{46OiCwTR?=MYLTRW5ITVJ?
NB13NU\GdYZUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXzJR|UxRTFzNz65PUBvVQ>?M3:wXnNCVkeHUh?=
GT3TKBNGTodnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFnkWmxKSzVyPUGxPE4xQCCwTR?=NV7uc5ByW0GQR1XS
BT-549Mk[zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MojvTWM2OD1zMUiuPVUhdk1?NF\h[m9USU6JRWK=
NCI-H747MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2DOcmlEPTB;MUG5MlM1KG6PMlzsV2FPT0WU
EW-1Mo\6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3vMSmlEPTB;MUKwMlIhdk1?MULTRW5ITVJ?
LB831-BLCMYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkTuTWM2OD1zMkCuOlMhdk1?NWi1SHlzW0GQR1XS
NMC-G1NHrF[Y5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUWzc2Q1UUN3ME2xNlEvOTFibl2=M3nXb3NCVkeHUh?=
COLO-679Mm\TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVfJR|UxRTF{Mj6xOUBvVQ>?M131RnNCVkeHUh?=
HL-60MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmW0TWM2OD1zMkOuNUBvVQ>?NFXsXYRUSU6JRWK=
MKN7MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NELCOINKSzVyPUGyN{45OyCwTR?=M3LT[nNCVkeHUh?=
RERF-LC-MSM1;qPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH7hV45KSzVyPUGyOE4{OSCwTR?=M4HNdnNCVkeHUh?=
DMS-114NWPIUFVnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2LnOWlEPTB;MUK1MlA6KG6PNFnDTGlUSU6JRWK=
HuP-T4Mn\rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1myXGlEPTB;MUK2Mlk4KG6PM4fiXnNCVkeHUh?=
HCC2157NHLYdppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYLJR|UxRTF{Nz61JI5OMYnTRW5ITVJ?
SKG-IIIaNGDFW5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkjhTWM2OD1zMkiuPEBvVQ>?NULmUmJKW0GQR1XS
HCT-116M3;TcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH7udWlKSzVyPUGzNE43PCCwTR?=NH7wdWZUSU6JRWK=
BB30-HNCNXP1bYVtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MljpTWM2OD1zM{CuO|ghdk1?MmfUV2FPT0WU
KYSE-270M{XaN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYfWN4tSUUN3ME2xN|AvQDhibl2=M2n2VnNCVkeHUh?=
MFM-223NEDPW4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXTOWoVmUUN3ME2xN|EvPTFibl2=MmHqV2FPT0WU
NH-12MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWnMSWFqUUN3ME2xN|IvQTlibl2=Ml62V2FPT0WU
U-118-MGNFjQbWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NInPRZpKSzVyPUGzN{43OiCwTR?=M4HpbHNCVkeHUh?=
ESS-1MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHfWdoRKSzVyPUGzOU4yQCCwTR?=MnvoV2FPT0WU
D-247MGMYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUTJR|UxRTF|NT6yNUBvVQ>?MmW0V2FPT0WU
IGROV-1MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVO1Rmo5UUN3ME2xN|UvPzZibl2=NGjZXZpUSU6JRWK=
C-33-AMk\hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVvn[WpWUUN3ME2xN|UvQTdibl2=M3rz[nNCVkeHUh?=
NCI-H1693M1fwTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MojxTWM2OD1zM{[uNVIhdk1?NX\kblVuW0GQR1XS
MLMANUjvOZRWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWTJR|UxRTF|Nj61PEBvVQ>?M{LCXXNCVkeHUh?=
SK-N-ASMXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWTJR|UxRTF|Nz6xO{BvVQ>?NIHmSZFUSU6JRWK=
NCI-H1755M1P5Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHzzdHVKSzVyPUGzPE45PSCwTR?=MlP3V2FPT0WU
CHP-134MlvIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV;JR|UxRTF|OT61OUBvVQ>?NU\rU|JtW0GQR1XS
LS-513M3LQb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXO5UIJJUUN3ME2xOFAvQTFicF2=M1zOfXNCVkeHUh?=
TE-12MnTwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX3JR|UxRTF2MD65N{BvVQ>?NHm1WYFUSU6JRWK=
KNS-42MmrXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFHFc2FKSzVyPUG0OE4{KG6PM4DrU3NCVkeHUh?=
SJRH30MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTF2ND60OEBvVQ>?MofmV2FPT0WU
NCI-H1092M2PLUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFL4O|dKSzVyPUG0OE42OiCwTR?=NWXzZppvW0GQR1XS
H-EMC-SSMX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVvpZ|R2UUN3ME2xOFYvQDFibl2=M{fHSnNCVkeHUh?=
SK-MEL-3NFK5fnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1H4UGlEPTB;MUS3MlU2KG6PNV:5SnpNW0GQR1XS
SK-N-FIMW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NViyNmE4UUN3ME2xOFcvPTlibl2=NY\sboNYW0GQR1XS
NCI-H2126MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVfJR|UxRTF2OD6xOUBvVQ>?M1\RcnNCVkeHUh?=
NCI-H1299MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWj1dVRVUUN3ME2xOVAvOjJibl2=NIKwcYxUSU6JRWK=
CFPAC-1MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXjJR|UxRTF3MD62OkBvVQ>?NVPvU|hWW0GQR1XS
NCI-H661MkHLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXTJR|UxRTF3MT6yOkBvVQ>?NYjCTWJpW0GQR1XS
KYSE-70M{jJUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIH0[G5KSzVyPUG1NU44QSCwTR?=NVz1fpM2W0GQR1XS
SW900NHTUN2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWfJR|UxRTF3ND62OUBvVQ>?MYDTRW5ITVJ?
Ca-SkiMWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXrvVlZZUUN3ME2xOVYvOzlibl2=NH:wXpFUSU6JRWK=
HPAF-IIM4rlNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUX5PIxKUUN3ME2xOVYvPDdibl2=MlLRV2FPT0WU
LB2518-MELNYLKdJJST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUfJR|UxRTF3Nz6xJI5ONYO1Z41WW0GQR1XS
LC-2-adNYfoOmw6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVLHZ5VRUUN3ME2xOVgvPjJibl2=MnfjV2FPT0WU
HCC1806NVXHbHZ2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVXmco55UUN3ME2xOlcvQDhibl2=NHnXPFNUSU6JRWK=
UACC-62NWTzWpdwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYHJR|UxRTF4OD6wPUBvVQ>?NWSxUoRFW0GQR1XS
KM-H2NXHOVmJrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnrkTWM2OD1zN{CuOVghdk1?M{TUdnNCVkeHUh?=
NCI-H2347NILVVXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{Tv[mlEPTB;MUeyMlczKG6PM3O5OnNCVkeHUh?=
SCC-15M3La[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1e4R2lEPTB;MUezMlY3KG6PNVXkc3pWW0GQR1XS
BB49-HNCNH3S[W1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmfWTWM2OD1zN{OuPFEhdk1?MV;TRW5ITVJ?
GMS-10MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M37GRWlEPTB;MUezMlk1KG6PNIrzS5RUSU6JRWK=
NCI-H2052MkDkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NW\TWXpNUUN3ME2xO|QvQSCwTR?=MlPIV2FPT0WU
SW626Ml\2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXvJR|UxRTF5Nj6wOkBvVQ>?M2K4eHNCVkeHUh?=
MDA-MB-415NH;NV5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnLoTWM2OD1zN{[uOlEhdk1?M3;MT3NCVkeHUh?=
Saos-2MorMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlXRTWM2OD1zN{muN|Uhdk1?MUTTRW5ITVJ?
DK-MGNEe3cZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4HZemlEPTB;MUiwMlMhdk1?NETVXlNUSU6JRWK=
SNU-C2BMn3uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3fse2lEPTB;MUiwMlc{KG6PMn\xV2FPT0WU
A427MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3jLW2lEPTB;MUiyMlU4KG6PMWDTRW5ITVJ?
KP-N-YSMoDIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4HaRWlEPTB;MUi1JI5ONELLWo9USU6JRWK=
J82NIr1blVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3z2emlEPTB;MUi1MlE5KG6PM3HFZXNCVkeHUh?=
LS-411NNFmzfJVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX3JR|UxRTF6Nz6yPEBvVQ>?M{fwOXNCVkeHUh?=
HCC1937NUDNbYlPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYHJR|UxRTF6Nz60PUBvVQ>?M2raS3NCVkeHUh?=
OE33NV[5bIJIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmLxTWM2OD1zOEiuPVchdk1?M1OyOnNCVkeHUh?=
NB7M3zobGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVri[XdYUUN3ME2xPFkvQDlibl2=MkPxV2FPT0WU
SW684M1y5cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHzmVW1KSzVyPUG5Ok4yOyCwTR?=NYL1SFhzW0GQR1XS
HT-144MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3nEdWlEPTB;MUm2MlE2KG6PNWPyZYVKW0GQR1XS
SK-MEL-30NVvKNJlRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWLpdFVMUUN3ME2xPVYvOiCwTR?=NH3qfmpUSU6JRWK=
DBTRG-05MGM1X3cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWXzXZlHUUN3ME2xPVgvPDdibl2=NYfYUolnW0GQR1XS
NCI-H1395MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1HONmlEPTB;MUm4Mlg2KG6PMXHTRW5ITVJ?
NCI-H2122M321cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUjJR|UxRTJyMD61PUBvVQ>?M4PuSXNCVkeHUh?=
no-10MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYnJR|UxRTJyMT6wOEBvVQ>?MkO5V2FPT0WU
SW48M4rPXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmjCTWM2OD1{MEGuN|Ehdk1?NHjSZYNUSU6JRWK=
NCI-H1650NHu0UFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVfJR|UxRTJyND6wNUBvVQ>?MV\TRW5ITVJ?
MZ1-PCMo\wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2rHOmlEPTB;MkC1MlU5KG6PMmLzV2FPT0WU
U-266MnPSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2DVSGlEPTB;MkC1Mlc6KG6PMV;TRW5ITVJ?
CAS-1MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX;JR|UxRTJyNz60OEBvVQ>?NW[zXGszW0GQR1XS
AU565NYC1V29HT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXrJR|UxRTJzMj64NkBvVQ>?NHOybpRUSU6JRWK=
UACC-257NFTUcoVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXr2N5JmUUN3ME2yNVMvQTlibl2=NF7ObIRUSU6JRWK=
CAL-27MoXuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX7JR|UxRTJzNz6wOUBvVQ>?NYPnc5RlW0GQR1XS
NCI-H23NFyze|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlP1TWM2OD1{MUmuN|Mhdk1?NX3MUYVjW0GQR1XS
TE-6M3iyTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF7WSYFKSzVyPUKxPU43QCCwTR?=NGPBOnRUSU6JRWK=
TGBC24TKBNIG0[ndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{nmOmlEPTB;MkKyMlE4KG6PM2jo[nNCVkeHUh?=
TE-1M1XTOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M37xUGlEPTB;MkKyMlg5KG6PMXPTRW5ITVJ?
RCC10RGBMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1rJcGlEPTB;MkK0MlE6KG6PM2XXVnNCVkeHUh?=
NCI-H596NWmzdFN3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MY\JR|UxRTJ{OD6yNkBvVQ>?MnLtV2FPT0WU
SW954M3nnT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHzWPFlKSzVyPUKzN{45OyCwTR?=NYDUToxpW0GQR1XS
NCI-H2087NVy5fGN{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NETBTmFKSzVyPUKzOE42OSCwTR?=NIrhRoJUSU6JRWK=
SK-PN-DWMnjMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3;MeGlEPTB;MkO1MlE6KG6PMVjTRW5ITVJ?
KM12NFvEbGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHv6TIpKSzVyPUKzOU44KG6PMmrXV2FPT0WU
BT-474MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVLJR|UxRTJ|NT63N{BvVQ>?M2TKOHNCVkeHUh?=
IST-MES1MlHXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEGydWJKSzVyPUKzOk42PyCwTR?=NWjKZpNPW0GQR1XS
HT-1197M1HmN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoDzTWM2OD1{M{iuNFkhdk1?Mo\4V2FPT0WU
CAL-54MmDPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXnhNHBsUUN3ME2yN|gvPDlibl2=MnvkV2FPT0WU
NB10NHnHN5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWXJR|UxRTJ2MD6wOkBvVQ>?M4fwZ3NCVkeHUh?=
PANC-10-05M{nnd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnT6TWM2OD1{NEWuOVYhdk1?MmfjV2FPT0WU
NCI-H522MlPxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn7yTWM2OD1{NEiuN|Ehdk1?NV\RfIZ4W0GQR1XS
A388MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnnWTWM2OD1{NEmuPFIhdk1?MmT2V2FPT0WU
GOTOMnu1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIe5b3VKSzVyPUK1NE4zQSCwTR?=MU\TRW5ITVJ?
KLENVTl[YdbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnGwTWM2OD1{NUGuPFchdk1?NWTwdpNRW0GQR1XS
KYSE-520MnvuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXWwNWNDUUN3ME2yOVIvQDZibl2=NVjHNmFZW0GQR1XS
HCE-4NXWzT|R{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWW1eowxUUN3ME2yOlIvPSCwTR?=NFHqe3VUSU6JRWK=
KURAMOCHIM3PDTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NW\IbXJiUUN3ME2yOlUvQSCwTR?=NVHlOXhCW0GQR1XS
HCC38MmnqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnjUTWM2OD1{Nk[uOFghdk1?M4nlWnNCVkeHUh?=
FADUMlfuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH25ZY5KSzVyPUK2Ok43OyCwTR?=NVS1PWhMW0GQR1XS
CW-2NXXVc49NT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1rNZ2lEPTB;Mk[5Mlk3KG6PNHLINIFUSU6JRWK=
L-428NXPJVGJST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3XucWlEPTB;Mke1MlE2KG6PNI[1dm1USU6JRWK=
HCC1569NVrNWHdXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXHJR|UxRTJ5NT64OEBvVQ>?NV73RYs3W0GQR1XS
NCI-H810Mm\sS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVK1fGFjUUN3ME2yO|gvOzFibl2=NYPUcmJiW0GQR1XS
LB771-HNCM4nuR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmfWTWM2OD1{OEWuPFQhdk1?NEXESHJUSU6JRWK=
LCLC-103HNYjrbZhzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M12yZ2lEPTB;Mki1Mlk6KG6PMkSyV2FPT0WU
EFO-21MnjHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGrwOIpKSzVyPUK4O{43QCCwTR?=NELUSm1USU6JRWK=
CAL-72Ml:xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoTTTWM2OD1{OUOuNVkhdk1?MonTV2FPT0WU
SCC-9Mn3PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVzFcFJxUUN3ME2yPVMvOjJibl2=NFS5bGxUSU6JRWK=
COLO-829MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXvJR|UxRTJ7Nj61JI5ONYrEPWpkW0GQR1XS
U-87-MGMmXsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFP6OJVKSzVyPUOwNE44OyCwTR?=M1eyUnNCVkeHUh?=
MZ7-melM2jhNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1;H[2lEPTB;M{KzMlc3KG6PNIK4PXBUSU6JRWK=
NCI-H1770NWrQfFZbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mm\ETWM2OD1|Mk[uO|Qhdk1?MYPTRW5ITVJ?
ChaGo-K-1NXvTXoE2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWPJR|UxRTN{OD6xJI5ONInxc|FUSU6JRWK=
SiHaNETFcnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXvZbpREUUN3ME2zNlkvOjRibl2=M17qbnNCVkeHUh?=
NCI-SNU-5MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{fiPGlEPTB;M{O2Mlc4KG6PNXi5e3RjW0GQR1XS
DJM-1NITXWmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3PZfWlEPTB;M{SwMlM{KG6PNV3GO4FRW0GQR1XS
OE19NYPQ[HR[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4PWNmlEPTB;M{SwMlU{KG6PNYCwV41ZW0GQR1XS
NCI-H1651Mn3iS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{C1[GlEPTB;M{S0MlE5KG6PNWXKTmV[W0GQR1XS
COLO-792Mn7BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M17vb2lEPTB;M{W0MlQzKG6PM1;IdXNCVkeHUh?=
ACHNMVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{[3TWlEPTB;M{W2MlcyKG6PMWfTRW5ITVJ?
TH-3NYfkRY5{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NITFXldKSzVyPUO3PU46PSCwTR?=NGj2TWNUSU6JRWK=
HT-1376M1HVbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF\FTVJKSzVyPUO4OE45QCCwTR?=NXzyZ|hPW0GQR1XS
RH-18MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2DsPGlEPTB;M{m0Mlc1KG6PNHTHXZRUSU6JRWK=
NB6M4C5Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3jqNGlEPTB;M{m2MlY3KG6PNX7pSnhuW0GQR1XS
COLO-320-HSRMXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXn6[nJGUUN3ME20NFMvOzdibl2=MoHEV2FPT0WU
UACC-893NIL5ZpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NE\BW4lKSzVyPUSwOk41PyCwTR?=MorPV2FPT0WU
DSH1NEDGWJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWTQS2pJUUN3ME20NFYvQTFibl2=M1HtXXNCVkeHUh?=
TE-10NYGxfnBWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml\rTWM2OD12MEeuNFEhdk1?MlX4V2FPT0WU
HCC70NFLnZW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHLoSJhKSzVyPUSwPU4zOSCwTR?=MkmwV2FPT0WU
TGBC11TKBM1XZOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH;VNVVKSzVyPUSxNE4{OyCwTR?=MorlV2FPT0WU
NCI-H727NWjVXVI4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF:3[XhKSzVyPUSxNk4yOSCwTR?=NH7sTplUSU6JRWK=
ALL-POMWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXPJR|UxRTRzNT62PUBvVQ>?MYrTRW5ITVJ?
ABC-1M3rVVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1;YTmlEPTB;NEKwMlQ2KG6PM1PJfHNCVkeHUh?=
NCI-H69MoDXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NW\uS21IUUN3ME20NlYvPzZibl2=MX7TRW5ITVJ?
GP5dNVr0R5lvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkT2TWM2OD12M{SuOFEhdk1?NY\admUxW0GQR1XS
UMC-11NEHGbWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3HmcGlEPTB;NEW4MlM3KG6PMXnTRW5ITVJ?
RMG-INWXVXZRjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4\kbGlEPTB;NE[3MlU3KG6PMWXTRW5ITVJ?
YAPCNIe1PWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2XiNGlEPTB;NEmwMlYhdk1?M2rpcHNCVkeHUh?=
LS-1034MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmK1TWM2OD12OUGuNFYhdk1?NVPPVFhkW0GQR1XS
RCM-1M3LQT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVXJR|UxRTR7Nj62PEBvVQ>?NVPiO4JyW0GQR1XS
HCC1954MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnW1TWM2OD13MUKuOUBvVQ>?NFvM[5pUSU6JRWK=
SK-MEL-24NFrzPGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVTJR|UxRTVzNj61NUBvVQ>?MlfkV2FPT0WU
NB12MoW4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXvJR|UxRTV{OD60NkBvVQ>?M1jHVXNCVkeHUh?=
SW756Mn3qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVi5dY5oUUN3ME21OVQvQTZibl2=Mk\yV2FPT0WU
HCC1187Mlq2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIrFTHBKSzVyPUW3OU45OyCwTR?=M13wVnNCVkeHUh?=
NCI-H2342M1TLbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2rTdWlEPTB;NUmwMlM6KG6PNWXXNI9zW0GQR1XS
NCI-H2291M4\Ufmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVnuZ4ZRUUN3ME21PVgvOzFibl2=MXvTRW5ITVJ?
OVCAR-3MojZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2DobGlEPTB;NUm4Mlk3KG6PMlj4V2FPT0WU
MHH-NB-11MkXCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGnuTIpKSzVyPU[yPU4xOSCwTR?=NF\iZYNUSU6JRWK=
SASMoLMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYLJR|UxRTZ3Mj62O{BvVQ>?MmizV2FPT0WU
COLO-824MmHTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWrJR|UxRTZ6OT6zO{BvVQ>?M17rO3NCVkeHUh?=
HCC1395NGPyPJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn7zTWM2OD14OUiuOUBvVQ>?MnfLV2FPT0WU
COLO-668NGjjZYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYXDeIh7UUN3ME23NFYvOSCwTR?=NELUSmJUSU6JRWK=
NCI-H226Mn[zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHHnb2tKSzVyPUewO{45KG6PNGXx[|hUSU6JRWK=
NB17NEDVO2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmS2TWM2OD15MkGuO|Uhdk1?MlrvV2FPT0WU
SW1463NF7kNo5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTd|OT6xPUBvVQ>?MnnjV2FPT0WU
TGWMkDGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3HySmlEPTB;N{[wMlE2KG6PMXzTRW5ITVJ?
NCI-H526MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NILkWpdKSzVyPUiyN{42OyCwTR?=NUC1T|hpW0GQR1XS
COR-L88NGjrTWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml23TWM2OD16NEiuNVIhdk1?M2fJNnNCVkeHUh?=
NCI-H441M1i5RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVPvWpVoUUN3ME24PVUvOjJibl2=MmnPV2FPT0WU
NCI-H630NXX5RVlXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVnhd2VWUUN3ME25NVIvQTZibl2=NEKwTYFUSU6JRWK=
Mo-TM4HiRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlW5TWM2OD17NEeuPFghdk1?M2nWVHNCVkeHUh?=
JARNGT3eoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGnBO4tKSzVyPUm1Ok4zPCCwTR?=MoPVV2FPT0WU
NCI-H1838MkLnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NG[4[XZKSzVyPUGuNFI{QDhizszNM4XzZXNCVkeHUh?=
DoTc2-4510M3nQfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGDwWpNKSzVyPUGuNFc{PzZizszNMnW1V2FPT0WU
MKN28NWfQTGh5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUHDb4tiUUN3ME2xMlA6ODJ2IN88US=>Mn[xV2FPT0WU
HuP-T3NYLjbW52T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmP2TWM2OD1zLkGxPVA2KM7:TR?=MVfTRW5ITVJ?
TE-9MkSyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkLoTWM2OD1zLkGyPVc{KM7:TR?=NWPEUoJvW0GQR1XS
NYMoexS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH7WbY9KSzVyPUGuNVY4QTJizszNNU\F[oFxW0GQR1XS
HT55NGH0c5NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MULJR|UxRTFwM{GzOFQh|ryPMVXTRW5ITVJ?
SW837NETTfWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn3HTWM2OD1zLkOyPVc5KM7:TR?=MnrsV2FPT0WU
NCI-H2029NYeyPGtGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV3XcVZXUUN3ME2xMlQyPzlzIN88US=>NHm3dGhUSU6JRWK=
IST-SL1NYjuOVNPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmDpTWM2OD1zLkS0NlQh|ryPNFLPfGVUSU6JRWK=
COLO-741MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX\JR|UxRTFwNEm3O|Eh|ryPMULTRW5ITVJ?
LU-65M{WxSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWjJR|UxRTFwNkKyOFkh|ryPMULTRW5ITVJ?
NCI-H1304NVHmNGxQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWnJR|UxRTFwNkW0PVgh|ryPMnrmV2FPT0WU
KARPAS-299M{HuXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX7oOpBKUUN3ME2xMlc6PDd7IN88US=>MWnTRW5ITVJ?
NCI-H358M4\Wbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3Tze2lEPTB;MT65OVUxOyEQvF2=MV3TRW5ITVJ?
OAW-28NX3mWFF4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHy1R21KSzVyPUKuNFY6OTlizszNNET0fo5USU6JRWK=
C8166NF\ab4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXjDb5pHUUN3ME2yMlY{Ozl{IN88US=>MnfUV2FPT0WU
COLO-678MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NE[wN|BKSzVyPUKuPFM4PjhizszNM{SycnNCVkeHUh?=
SK-N-DZMUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmLETWM2OD1{Lki2N|gyKM7:TR?=MoW2V2FPT0WU
NCI-H82NX\mb2NUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUXJR|UxRTJwOUCzOlkh|ryPNIXKVpFUSU6JRWK=
JVM-2NGjNbYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV;JR|UxRTNwMEOxPFgh|ryPNXrScXp[W0GQR1XS
SW1116M3v2Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWKybJpiUUN3ME2zMlA2PDFzIN88US=>M1LDVHNCVkeHUh?=
MDA-MB-453M3PiTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYKx[pZyUUN3ME2zMlExPDN7IN88US=>MortV2FPT0WU
Calu-6MoXDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmPmTWM2OD1|LkG5PVch|ryPMlHqV2FPT0WU
SHP-77NULreHpqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmK4TWM2OD1|LkWyPEDPxE1?MmLJV2FPT0WU
Capan-2MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnvTTWM2OD12LkOyOVgyKM7:TR?=NXLJU4Y3W0GQR1XS
SW948NED1UlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlzRTWM2OD12Lke0O|c6KM7:TR?=NYKyfXVCW0GQR1XS
HDLM-2NXixPYp5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NULXRmtEUUN3ME21MlA4PzJ3IN88US=>NV34NotSW0GQR1XS
LAN-6MkTlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoPoTWM2OD14LkKxOFk2KM7:TR?=NX7vO5NQW0GQR1XS
LU-135NFfDSlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEK2R4FKSzVyPU[uOFMxPzdizszNNV3qUVdDW0GQR1XS
T84MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH;JSnRKSzVyPU[uPVg3PCEQvF2=MoDKV2FPT0WU
CAPAN-1NHzEelBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGXxemtKSzVyPUeuOlIzOzNizszNNYrHOZhQW0GQR1XS
SW1417M{TjSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXT5bGtZUUN3ME23MlkyPzNzIN88US=>NH\ydGlUSU6JRWK=
BALL-1NFrEVlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYL6d3VHUUN3ME24MlUxPDB7IN88US=>NE\heZBUSU6JRWK=
HT-29M1vLNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVzJR|UxRTlwMEe1PVkh|ryPNFfOcYVUSU6JRWK=
C3ANH7ndndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2DiXWlEPTB;OT64PFM6PCEQvF2=Mm\HV2FPT0WU
NCI-H1993NWTGUlR3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXHufYsyUUN3ME2xNE42ODhzIN88US=>MljoV2FPT0WU
SK-MEL-1M{GzTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml;hTWM2OD1zMT62Nlg6KM7:TR?=NFe4V4hUSU6JRWK=
DU-145M2Sze2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYPJR|UxRTF2LkWwOVIh|ryPM4H6W3NCVkeHUh?=
KP-N-YNMYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1nyemlEPTB;MUSuOVExOyEQvF2=M3nQRXNCVkeHUh?=
CCRF-CEMNITrfXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mo\LTWM2OD1zND63PFA6KM7:TR?=MUjTRW5ITVJ?
ZR-75-30M4j2c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2L5NWlEPTB;MU[uN|MxOyEQvF2=M1nVcnNCVkeHUh?=
A673NFiwdHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlKwTWM2OD1{MD61OVA4KM7:TR?=NVrIcZpuW0GQR1XS
K-562MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIXTN3NKSzVyPUK4MlQyQDNizszNNVX3bGFHW0GQR1XS

... Click to View More Cell Line Experimental Data

In vivo BEZ235 induces regression of the tumors (69%) without statistically significant effect on body weight gain. Altogether, these preliminary in vivo efficacy results show that BEZ235 causes disease stasis when administered orally as a single agent and can enhance the efficacy of other anticancer agents when used in combination studies. [1]
Features

Protocol(Only for Reference)

Kinase Assay:

[1]

In vitro Protein Kinase, PI3K, and mTOR Assays PI3Kα, β, and δ proteins are composed of the iSH2 domain of p85 NH2-terminally fused to the full-length protein p110 protein, with the exception of α that also does not contain the last 20 amino acids. PI3Kγ is produced as full-length protein deleted for its first 144 amino acids. All constructs are fused to a COOH-terminal His tag for convenient purification and then cloned into the pBlue-Bac4.5 (for α, β, and δ isoforms) or pVL1393 (for γ isoform) plasmids. The different vectors are then cotransfected with BaculoGold WT genomic DNA using methods recommended by the vendor for production of the respective recombinant baculoviruses and proteins. BEZ235 are tested for their activity against PI3K using a Kinase-Glo assay. The kinase reaction is done in 384-well black plate. Each well is loaded with 50 μL of test items (in 90% DMSO) and 5 μL reaction buffer containing 10 μg/mL PI substrate (l-α-phosphatidylinositol; Avanti Polar Lipids; prepared in 3% octyl-glucoside) and the PI3K proteins (10, 25, 10, and 150 nM of p110α, p110β, p110δ, and p110γ, respectively) are then added to it. The reaction is started by the addition of 5 μL of 1 μM ATP prepared in the reaction buffer and is incubated for either 60 (for p110α, p110β, and p110δ) or 120 min (for p110γ). It is terminated by the addition of 10 μL Kinase-Glo buffer. The plates are then read in a Synergy 2 reader for luminescence detection.

Cell Assay:

[2]

Cell lines HCT116, DLD-1 and SW480 cells
Concentrations 0-1 μM
Incubation Time 48 hours
Method

The human CRC cell lines, HCT116 (PIK3CA mutant; kinase domain at H1047R), DLD-1 (PIK3CA mutant; helical domain at E545K), and SW480 (PIK3CA wild-type) and isogenic DLD-1 PIK3CA mutant as well as wild-type cells are maintained in DMEM with 10% FBS and 1 × Penicillin/Streptomycin. Cells are plated at different initial densities (HCT116: 3 × 103 cells/well, DLD-1: 5.5 × 103 cells/well, SW480: 4.5 × 103 cells/well, DLD-1 PIK3CA mutant: 7 × 103 cells/well, and DLD-1 PIK3CA wild-type: 9 × 103 cells/well) to account for differential growth kinetics. After 16 hours, cells are incubated with increasing concentrations of BEZ235, and the drug-containing growth medium is changed every 24 hours. Cell viability is assessed 16 hours after the initial plating and 48 hours after initiation of drug treatment using the colorimetric MTS assay CellTiter 96® AQueous One Solution Cell Proliferation Assay, as per the manufacturer's instructions. Cell viability after drug treatment is normalized to that of untreated cells also grown for 48 hours. For western blot analysis, cells are plated with zero or maximum inhibitory dose (500 nM) BEZ235 for 2, 6, 24, or 48 hours.

Animal Study:

[1]

Animal Models Female Harlan athymic nude mice
Formulation NMP/polyethylene glycol 300 (10/90, v/v)
Dosages 45 mg/kg
Administration p.o.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Maira SM, et al. Mol Cancer Ther, 2008, 7(7), 1851-1863.

[2] Roper J, et al. PLoS One, 2011, 6(9), e25132.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-30)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT01856101 Terminated Carcinoma Transitional Cell Cliniques universitaires Saint-Luc- Université Catholique  ...more Cliniques universitaires Saint-Luc- Université Catholique de Louvain|Novartis February 2013 Phase 2
NCT01717898 Terminated Castrate-resistant Prostate Cancer Patients. Charles Ryan|Novartis Pharmaceuticals|University of Calif  ...more Charles Ryan|Novartis Pharmaceuticals|University of California, San Francisco January 2013 Phase 1|Phase 2
NCT01658436 Completed Pancreatic Neuroendocrine Tumors (pNET) Novartis Pharmaceuticals|Novartis November 2012 Phase 2
NCT01628913 Terminated Pancreatic Neuroendocrine Tumors (pNET) Novartis Pharmaceuticals|Novartis October 2012 Phase 2
NCT01690871 Withdrawn Malignant PEComa (Perivascular Epithelioid Cell Tumors) Novartis Pharmaceuticals|Novartis September 2012 Phase 2

view more

Chemical Information

Download BEZ235 (NVP-BEZ235, Dactolisib) SDF
Molecular Weight (MW) 469.55
Formula

C30H23N5O

CAS No. 915019-65-7
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMF 18 mg/mL warming (38.33 mM)
DMSO 0.01 mg/mL (0.02 mM)
Water <1 mg/mL (<1 mM)
In vivo NMP+polyethylene glycol 300 (10+90, v+v) 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl)phenyl)propanenitrile

Frequently Asked Questions

  • Question 1
    With difficulties in dissolving BEZ235, How can I improve its solubility?

    Answer: For in vivo study, we suggest the vehicle solution NMP/polyethylene glycol 300 (10/90, v/v). Please dissolve BEZ235 in NMP as more as possible. You can sonicate and warm it in water bath for a while. Then dilute with PEG 300.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related PI3K Products

  • GDC-0032

    GDC-0032 is a potent, next-generation β isoform-sparing PI3K inhibitor targeting PI3Kα/δ/γ with Ki of 0.29 nM/0.12 nM/0.97nM, >10 fold selective over PI3Kβ.

    Features:A beta isoform-sparing PI3K inhibitor.

  • Pilaralisib (XL147)

    Pilaralisib (XL147) is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ with IC50 of 39 nM/36 nM/23 nM in cell-free assays, less potent to PI3Kβ. Phase 1/2.

  • GNE-317

    GNE-317 is a potent, brain-penetrant PI3K inhibitor.

  • LY294002

    LY294002 is the first synthetic molecule known to inhibit PI3Kα/δ/β with IC50 of 0.5 μM/0.57 μM/0.97 μM in cell-free assays, respectively; more stable in solution than Wortmannin, and also blocks autophagosome formation.

  • 3-Methyladenine (3-MA)

    3-Methyladenine (3-MA) is a selective PI3K inhibitor for Vps34 and PI3Kγ with IC50 of 25 μM and 60 μM in HeLa cells; blocks class I PI3K consistently, whereas suppression of class III PI3K is transient, and also blocks autophagosome formation.

  • CAL-101 (Idelalisib, GS-1101)

    CAL-101 (Idelalisib, GS-1101) is a selective p110δ inhibitor with IC50 of 2.5 nM in cell-free assays; shown to have 40- to 300-fold greater selectivity for p110δ than p110α/β/γ, and 400- to 4000-fold more selectivity to p110δ than C2β, hVPS34, DNA-PK and mTOR.

  • Wortmannin

    Wortmannin is the first described PI3K inhibitor with IC50 of 3 nM in a cell-free assay, with little selectivity within the PI3K family. Also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM in cell-free assays.

  • BKM120 (NVP-BKM120, Buparlisib)

    BKM120 (NVP-BKM120, Buparlisib) is a selective PI3K inhibitor of p110α/β/δ/γ with IC50 of 52 nM/166 nM/116 nM/262 nM in cell-free assays, respectively. Reduced potency against VPS34, mTOR, DNAPK, with little activity to PI4Kβ. Phase 2.

  • Pictilisib (GDC-0941)

    Pictilisib (GDC-0941) is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM in cell-free assays, with modest selectivity against p110β (11-fold) and p110γ (25-fold). Phase 2.

  • Alpelisib (BYL719)

    Alpelisib (BYL719) is a potent and selective PI3Kα inhibitor with IC50 of 5 nM in a cell-free assay, and minimal effect on PI3Kβ/γ/δ. Phase 2.

Recently Viewed Items

Tags: buy BEZ235 (NVP-BEZ235, Dactolisib) | BEZ235 (NVP-BEZ235, Dactolisib) supplier | purchase BEZ235 (NVP-BEZ235, Dactolisib) | BEZ235 (NVP-BEZ235, Dactolisib) cost | BEZ235 (NVP-BEZ235, Dactolisib) manufacturer | order BEZ235 (NVP-BEZ235, Dactolisib) | BEZ235 (NVP-BEZ235, Dactolisib) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us